Swiss Medtech Expo 365

My Account

Language

Video

The new standard for controlling cardiac resynchronization therapy in heart failure

Although cardiac resynchronization therapy (CRT) is successful in treating heart failure, there is room for improvement, as 30–40% of heart failure patients do not respond to the therapy. Learn how we can specifically maximize the individual response to CRT in Nico Drost's presentation.

Zign Group
Nieuwegein, Netherlands

Speaker

Nico Drost, Zign Group, CEO

Your contact person

Nico Drost

Nico Drost

CEO

Applaud – up to 10 times

0

Share post

Related topics (3)

Public applause by users